GSK plc (GLAXF)

USD 17.26

(-0.4%)

Net Debt Summary of GSK plc

  • GSK plc's latest annual net debt in 2023 was 15.08 Billion GBP , down -12.64% from previous year.
  • GSK plc's latest quarterly net debt in 2024 Q1 was 14.98 Billion GBP , down -0.66% from previous quarter.
  • GSK plc reported annual net debt of 17.26 Billion GBP in 2022, down -13.24% from previous year.
  • GSK plc reported annual net debt of 19.89 Billion GBP in 2021, down -4.6% from previous year.
  • GSK plc reported quarterly net debt of 14.98 Billion GBP for 2024 Q1, down -0.66% from previous quarter.
  • GSK plc reported quarterly net debt of 18.33 Billion GBP for 2023 Q2, up 1.77% from previous quarter.

Annual Net Debt Chart of GSK plc (2023 - 1989)

Historical Annual Net Debt of GSK plc (2023 - 1989)

Year Net Debt Net Debt Growth
2023 15.08 Billion GBP -12.64%
2022 17.26 Billion GBP -13.24%
2021 19.89 Billion GBP -4.6%
2020 20.85 Billion GBP -19.16%
2019 25.8 Billion GBP 16.27%
2018 22.19 Billion GBP 67.4%
2017 13.25 Billion GBP -4.59%
2016 13.89 Billion GBP 28.62%
2015 10.8 Billion GBP -25.22%
2014 14.44 Billion GBP 13.65%
2013 12.71 Billion GBP -9.97%
2012 14.11 Billion GBP 53.67%
2011 9.18 Billion GBP 1.59%
2010 9.04 Billion GBP -6.89%
2009 9.71 Billion GBP -8.07%
2008 10.56 Billion GBP 46.89%
2007 7.19 Billion GBP 106.37%
2006 3.48 Billion GBP 54.07%
2005 2.26 Billion GBP -35.3%
2004 3.49 Billion GBP -15.58%
2003 4.14 Billion GBP 15.32%
2002 3.59 Billion GBP 1.91%
2001 3.52 Billion GBP 28.18%
2000 2.74 Billion GBP -16.52%
1999 3.29 Billion GBP 14.3%
1998 2.88 Billion GBP 2.64%
1997 2.8 Billion GBP -5.93%
1996 2.98 Billion GBP -29.57%
1995 4.23 Billion GBP 586.71%
1994 617 Million GBP -17.29%
1993 746 Million GBP 55.74%
1992 479 Million GBP -50.97%
1991 977 Million GBP 381.28%
1990 203 Million GBP 150.62%
1989 -401 Million GBP -279.02%

Peer Net Debt Comparison of GSK plc

Name Net Debt Net Debt Difference
AstraZeneca PLC 22.74 Billion USD 33.705%
Bristol-Myers Squibb Company PFD CONV 2 30 Billion USD 49.727%
CSPC Pharmaceutical Group Limited -1.59 Billion USD 1046.149%
Clarus Therapeutics Holdings, Inc. 15.85 Million USD -95030.566%
Novartis AG 12.95 Billion USD -16.418%
PT Kalbe Farma Tbk. -169.7 Million USD 8987.366%